Your session is about to expire
← Back to Search
Contact Lens Wear for Fuchs' Dystrophy
Study Summary
This trial will compare corneal thickness in healthy vs unhealthy eyes to see if there is a difference in response to contact lens placement.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- I am willing to undergo eye imaging tests.I have been diagnosed with Fuchs' dystrophy.I have never had eye diseases like surface issues or glaucoma.I am scheduled for a corneal transplant within the next 6 months.I have never had eye surgery on my study eye.
- Group 1: Subjects with Fuch's Endothelial Dystrophy
- Group 2: Subjects with healthy eyes
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there currently any openings for participants in this research?
"According to clinicaltrials.gov, this medical experiment is currently enrolling participants. Initially posted on the 1st of July in 2023 and recently updated on the 25th of January in 2023."
How many individuals are being granted admittance to this research endeavor?
"Affirmative. Clinicaltrials.gov gathers that this medical trial, posted on July 1st 2023 and recently revisited on January 25th 2023, is presently searching for eligible volunteers. The study requires the recruitment of around twenty individuals from a single centre."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger